Literature DB >> 14582144

Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects.

Judith Gault1, Janet Hopkins, Ralph Berger, Carla Drebing, Judith Logel, Catherine Walton, Margaret Short, Ruby Vianzon, Ann Olincy, Randal G Ross, Lawrence E Adler, Robert Freedman, Sherry Leonard.   

Abstract

The hypothesis that the 15q13-15 region of chromosome 15 contains a gene that contributes to the etiology of schizophrenia is supported by multiple genetic linkage studies. The alpha7 neuronal nicotinic acetylcholine receptor (CHRNA7) gene was selected as the best candidate gene in this region for molecular investigation, based on these linkage findings and biological evidence in both human and rodent models. CHRNA7 receptors are decreased in expression in postmortem brain of schizophrenic subjects. A dinucleotide marker, D15S1360, in intron two of the CHRNA7 gene is genetically linked to an auditory gating deficit found in schizophrenics and half of the first-degree relatives of patients. Single strand conformation polymorphism (SSCP) and sequence analyses of DNA from schizophrenic and control individuals identified 33 variants in the coding region and intron/exon borders of the CHRNA7 gene and its partial duplication, dupCHRNA7; common polymorphisms were mapped. Twenty-one variants were found in the exons, but non-synonymous changes were rare. Although the expression of CHRNA7 is decreased in schizophrenia, the general structure of the remaining receptors is likely to be normal. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14582144     DOI: 10.1002/ajmg.b.20061

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  33 in total

1.  Function of partially duplicated human α77 nicotinic receptor subunit CHRFAM7A gene: potential implications for the cholinergic anti-inflammatory response.

Authors:  Ana M de Lucas-Cerrillo; M Constanza Maldifassi; Francisco Arnalich; Jaime Renart; Gema Atienza; Rocío Serantes; Jesús Cruces; Aurora Sánchez-Pacheco; Eva Andrés-Mateos; Carmen Montiel
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

2.  Association study of the 2-bp deletion polymorphism in exon 6 of the CHRFAM7A gene with idiopathic generalized epilepsy.

Authors:  Agata Rozycka; Jolanta Dorszewska; Barbara Steinborn; Margarita Lianeri; Anna Winczewska-Wiktor; Aleksandra Sniezawska; Kamila Wisniewska; Pawel P Jagodzinski
Journal:  DNA Cell Biol       Date:  2013-09-11       Impact factor: 3.311

3.  Spatial and intracellular relationships between the alpha7 nicotinic acetylcholine receptor and the vesicular acetylcholine transporter in the prefrontal cortex of rat and mouse.

Authors:  A M Duffy; P Zhou; T A Milner; V M Pickel
Journal:  Neuroscience       Date:  2009-04-15       Impact factor: 3.590

4.  A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia.

Authors:  Melissa L Sinkus; Michael J Lee; Judith Gault; Judith Logel; Margaret Short; Robert Freedman; Susan L Christian; Jennifer Lyon; Sherry Leonard
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

5.  Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders.

Authors:  D T Miller; Y Shen; L A Weiss; J Korn; I Anselm; C Bridgemohan; G F Cox; H Dickinson; J Gentile; D J Harris; V Hegde; R Hundley; O Khwaja; S Kothare; C Luedke; R Nasir; A Poduri; K Prasad; P Raffalli; A Reinhard; S E Smith; M M Sobeih; J S Soul; J Stoler; M Takeoka; W-H Tan; J Thakuria; R Wolff; R Yusupov; J F Gusella; M J Daly; B-L Wu
Journal:  J Med Genet       Date:  2008-09-19       Impact factor: 6.318

6.  The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function.

Authors:  Tanguy Araud; Sharon Graw; Ralph Berger; Michael Lee; Estele Neveu; Daniel Bertrand; Sherry Leonard
Journal:  Biochem Pharmacol       Date:  2011-06-28       Impact factor: 5.858

7.  AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation.

Authors:  Dominik Feuerbach; Nicole Pezous; Markus Weiss; Kasra Shakeri-Nejad; Kurt Lingenhoehl; Daniel Hoyer; Konstanze Hurth; Graeme Bilbe; Christopher R Pryce; Kevin McAllister; Frederique Chaperon; Klaus Kucher; Donald Johns; Thomas Blaettler; Cristina Lopez Lopez
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 8.  Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.

Authors:  Jason Smucny; Jason R Tregellas
Journal:  J Psychopharmacol       Date:  2017-04-26       Impact factor: 4.153

9.  Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia.

Authors:  Sarah H Stephens; Judith Logel; Amanda Barton; Alexis Franks; Jessica Schultz; Margaret Short; Jane Dickenson; Benjamin James; Tasha E Fingerlin; Brandie Wagner; Colin Hodgkinson; Sharon Graw; Randal G Ross; Robert Freedman; Sherry Leonard
Journal:  Schizophr Res       Date:  2009-01-31       Impact factor: 4.939

10.  Copy number variations and cancer.

Authors:  Adam Shlien; David Malkin
Journal:  Genome Med       Date:  2009-06-16       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.